C. R. BARD, INC. for C R BARD INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY P GLASS | — |
Consumer Issues/Safety/Products CSP
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY P GLASS | — |
Taxation/Internal Revenue Code TAX
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY P GLASS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.